Author: healthadmin

Novartis Chief Executive Vasu Narasimhan said Europe needed a “complete rethink” of how medicines are priced, warning that it could delay the entry of new medicines into the market. In his comments on Tuesday, Narasimhan echoed calls from leaders of other European drug companies, including Roche and AstraZeneca, who have criticized Europe’s health policy for stifling innovation. Roche CEO Thomas Schinecker last week called Europe’s bureaucracy and overregulation “alarming” and warned that the continent was falling further behind the United States and China as industry innovators. The criticism comes after industry leaders including Novartis, Roche and AstraZeneca struck most-favored-nation (MFN)…

Pfizer’s decision to agree to the last of three settlements to delay the launch of counterfeit versions of its transthyretin amyloid cardiomyopathy (ATTR-CM) drug Vindamax was expected to be good news for BridgeBio and its rival drug Atruvy. But analysts say that while it’s definitely a boon for Pfizer, the outcome will be mixed for BridgeBio because the agreement’s earlier-than-expected entry date for generic drugs. Recently, Pfizer resolved a dispute with Dexel Pharma and Cipla over generic Tafamizi. Now, Pfizer announced on Tuesday that it has also reached an agreement with Hikma Pharmaceuticals, successfully preventing the entry of Tafamizi generics…

The FDA released a briefing document detailing its concerns about AstraZeneca cancer drug distributor and Tolcap ahead of an upcoming advisory committee meeting, its first in nearly nine months. Regarding AZ’s application for an oral SERD treatment, the FDA asserted that the company’s clinical trial plan does not allow it to determine whether a switch strategy would be beneficial compared to a progression-based treatment approach, where oral SERD is becoming the standard of care (PDF). AZ’s drug is being investigated in combination with a CDK4/6 inhibitor as a switch first-line therapy for patients with HR-positive, HER2-negative breast cancer who develop…

Have you ever paid more for a product just because the brand said it was good for you and the planet? Many activewear shoppers do exactly this, believing that the “healthy” image on the label matches what’s actually in the fabric. That trust is now being questioned. The Texas Attorney General’s Office has launched a formal investigation into activewear brand Lululemon. Question: Does that activewear contain PFAS, a group of toxic “permanent chemicals”? This is off-putting for a brand built on wellness. Lululemon denies the claims. The company says it will phase out PFAS in 2023 and that these chemicals…

New research published in nature communications It reveals that a brain chemical called acetylcholine can directly trigger the release of serotonin. These results suggest that the brain uses a highly coordinated system to link different chemical messengers. This finding could help explain the biological origins of compulsive behaviors seen in psychiatric disorders such as obsessive-compulsive disorder. The brain relies on a series of chemical messengers to transmit signals across the microscopic gaps between nerve cells. These chemicals allow the brain to coordinate everything from basic reflexes to abstract thinking. The striatum is a deep structure in the brain that serves…

Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, even in cases that are not detected by standard blood tests, according to a study published in December 2016. nature communications. Testicular cancer most commonly affects adolescents and young adults and is highly treatable, especially if detected early. However, diagnosis can be difficult if the tumor does not produce enough normal blood-based substances, called tumor markers, to be detected by standard tests. To solve this, researchers used a method that analyzes thousands of immune system signals in the…

A new study shows that single vascular cells that emerge early in laboratory-cultured skin organoids have the ability to form complex microvascular networks that grow and mature over time. These self-organizing structures function similarly to natural human skin structures, as they respond appropriately to compounds released by the body during inflammation and can regrow after injury. research in American Journal of PathologyThe paper published by Elsevier is the first to use this system to demonstrate microvascular responses to inflammatory stimuli and injury, which has major implications for understanding the important role of cutaneous blood vessels in inflammation, repair, regeneration, and…

The Patient-Centered Outcomes Research Institute (PCORI) today announced new funding to support patient-centered comparative clinical effectiveness research (CER) across the wide range of health conditions experienced by Americans and projects to help bring practice-changing CER results to real-world clinical settings. Across the United States, people make decisions about their health care without always having clear information about the potential benefits and risks of different treatment options. These awards are part of PCORI’s growing portfolio of funded research that supports projects that generate information that helps patients, caregivers, and the broader medical community choose care options and help integrate evidence into…

Childhood obesity remains a major health challenge, and effective interventions often require more than nutritional guidance and exercise plans. The structure of the day, family routines, school schedules, and holiday interruptions can affect how children eat, move, sleep, and spend screen time. In the Southern Hemisphere, summer vacation can reduce daily routines for an extended period of time, making it more difficult to maintain healthy habits. Seasonal patterns are discussed in international studies, but evidence from New Zealand is limited. Based on these challenges, more detailed research is needed to determine whether season of program entry influences outcomes of obesity…

There is growing concern about the health effects of exposure to chemicals known as PFAS. And new research has found that when pregnant women are exposed to so-called “forever chemicals,” their babies are more likely to be born prematurely and with low birth weight. It also increased the risk of infant mortality.The data comes from New Hampshire, and one of the researchers said the study attempted to uniquely isolate the effects of PFAS. The study’s authors include Derek LeMoyne and Ashley Langer. They are both professors of economics at the University of Arizona and co-directors of the Consortium for Green…